Chanapa Tantibanchachai, Press Officer for the FDA, told Reuters via email on Apthat this is the FDA’s most recent update and as such, the FDA has not changed its position on hydroxychloroquine since June 15, 2020. On Jthe FDA published a summary of their review of safety issues with the use of hydroxychloroquine to treat hospitalized patients with COVID-19, seen here. The FDA revoked the emergency use authorization (EUA) for hydroxychloroquine for the treatment of COVID-19 on June 15, 2020, after results from several clinical trials failed to show that HCQ could be safe and effective for treating or preventing COVID-19 ( here, here). He also said he was taking it himself, even after the FDA advised that its efficacy and safety were unproven ( here). President Trump said last March that hydroxychloroquine could be a game-changer in the coronavirus pandemic. Hydroxychloroquine is a medicine that is FDA-approved to treat arthritis and to treat or prevent malaria ( here). Food and Drug Administration (FDA), the National Institutes of Health (NIH) and the American Medical Association (AMA) told Reuters that their guidance advising against treating COVID-19 with hydroxychloroquine or urging caution reflects their current positions, as of this article’s publication.Įxamples of the posts can be seen here, here and here. Social media users have been sharing posts which claim that “hydroxychloroquine is now ok” yet the U.S.
0 kommentar(er)
